Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Visconti

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Hospital Pharmacy|September 1, 1977
Pharmacokinetics in drug therapy III: Clindamycin dosage regimens for treatment of chronic osteomyelitisP Schneider, J A Visconti
The New England Journal of Medicine|September 3, 1970
Orphenadrine and propoxypheneW H Puckett, J A Visconti
American Journal of Hospital Pharmacy|August 1, 1979
Relative drug safety and efficacy: any help for the practitioner?T D Rucker, J A Visconti
American Journal of Hospital Pharmacy|May 15, 1994
Emerging indications for octreotide therapy, Part 2K W Mosdell, J A Visconti
American Journal of Hospital Pharmacy|October 1, 1985
Change in Theragran formulationJ A Visconti, S M DeCenzo
American Journal of Hospital Pharmacy|April 1, 1985
National audit of drug information centersS R Dombrowski, J A Visconti
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 1, 1974
On the "costs" of the 1962 drug amendmentsM C Smith, J A Visconti
American Journal of Hospital Pharmacy|April 1, 1971
An epidemiological study of the clinical significance of drug-drug interactions in a private community hospitalW H Puckett, J A Visconti
American Journal of Hospital Pharmacy|December 1, 1971
Investigational drugsC J Latiolais, J A Visconti
American Journal of Hospital Pharmacy|September 1, 1976
Hospital formularies: organizational aspects and supplementary componentsT D Rucker, J A Visconti
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Hospital Pharmacy|September 1, 1977
Pharmacokinetics in drug therapy III: Clindamycin dosage regimens for treatment of chronic osteomyelitisP Schneider, J A Visconti
The New England Journal of Medicine|September 3, 1970
Orphenadrine and propoxypheneW H Puckett, J A Visconti
American Journal of Hospital Pharmacy|August 1, 1979
Relative drug safety and efficacy: any help for the practitioner?T D Rucker, J A Visconti
American Journal of Hospital Pharmacy|May 15, 1994
Emerging indications for octreotide therapy, Part 2K W Mosdell, J A Visconti
American Journal of Hospital Pharmacy|October 1, 1985
Change in Theragran formulationJ A Visconti, S M DeCenzo
American Journal of Hospital Pharmacy|April 1, 1985
National audit of drug information centersS R Dombrowski, J A Visconti
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 1, 1974
On the "costs" of the 1962 drug amendmentsM C Smith, J A Visconti
American Journal of Hospital Pharmacy|April 1, 1971
An epidemiological study of the clinical significance of drug-drug interactions in a private community hospitalW H Puckett, J A Visconti
American Journal of Hospital Pharmacy|December 1, 1971
Investigational drugsC J Latiolais, J A Visconti
American Journal of Hospital Pharmacy|September 1, 1976
Hospital formularies: organizational aspects and supplementary componentsT D Rucker, J A Visconti
Pageof 4